Clinical Trial Update: Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection [Phase 2]

View source ↗

Summary

This is a Phase 2 study update for PRO 140 (leronlimab) given subcutaneously to adults with HIV-1 infection. The trial has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PRO 140 (leronlimab) (leronlimab)

Snippet

Sponsor: CytoDyn, Inc. | Conditions: HIV -1 Infection, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2013-05-31